{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:30:52Z","timestamp":1792611052627,"version":"4.5.0"},"reference-count":202,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Prevalence of psychostimulant use is high, and raising in several countries. Nicotine is the legal stimulant causing the most important public health impact. Cocaine ranks among the most used illicit substances after cannabis. Stimulant medications are frequently misused. Psychostimulants can lead to addiction, have physical, psychological and social health consequences and can induce a great disease burden. The aim of the present article is to provide a literature review on the health effects of stimulants as potential drugs of abuse. It will cover essentially cocaine, amphetamines and its derivatives (including methamphetamines and 3-4-methylenedioxymethamphetamine, ecstasy), nicotine, caffeine and khat, and touch upon the issues of prescribed substances (anti-depressants, weight control medications, attention-deficit hyperactivity disorder medications, hypersomniac disorder). Their pharmacology, addictive potential, health consequences and treatment will be discussed. We used Medline for the literature review from 1990 to the date of this review, and mention the findings of human and animal studies (the latter only if they are of clinical relevance).<\/jats:p>","DOI":"10.3390\/ph3072333","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T12:15:33Z","timestamp":1279800933000},"page":"2333-2361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["The Health Effect of Psychostimulants: A Literature Review"],"prefix":"10.3390","volume":"3","author":[{"given":"Thierry","family":"Favrod-Coune","sequence":"first","affiliation":[{"name":"Division of Primary Care Medicine, Geneva University Hospitals 4, Rue Gabrielle-Perret-Gentil,1211 Geneva 14, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Broers","sequence":"additional","affiliation":[{"name":"Division of Primary Care Medicine, Geneva University Hospitals 4, Rue Gabrielle-Perret-Gentil,1211 Geneva 14, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999-2000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpedi.161.9.857","article-title":"Prevalence, recognition, and treatment of attention-deficit\/hyperactivity disorder in a national sample of US children","volume":"161","author":"Froehlich","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/08039480903511381","article-title":"The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review","volume":"64","author":"Knorr","year":"2010","journal-title":"Nord. J. Psychiatry"},{"key":"ref_6","unstructured":"Available online:http:\/\/www.who.int\/tobacco\/mpower\/en\/index.html\/."},{"key":"ref_7","unstructured":"(2009). Rapport annuel 2009 \u2014 \u00c9tat du ph\u00e9nom\u00e8ne de la drogue en Europe."},{"key":"ref_8","unstructured":"Proceedings of the Community Epidemiology Work Group. Available online:http:\/\/www.drugabuse.gov\/PDF\/CEWG\/AdvReport_Vol1_105.pdf\/,."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","article-title":"Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys","volume":"5","author":"Degenhardt","year":"2008","journal-title":"PLoS Med."},{"key":"ref_10","first-page":"411","article-title":"Pychostimulants","volume":"63","author":"Pinto","year":"2008","journal-title":"Rev Med Liege"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.CIR.0000046228.97025.3A","article-title":"Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking","volume":"106","author":"Corti","year":"2002","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0899-9007(00)00369-5","article-title":"Caffeine and nutrition","volume":"16","author":"Harland","year":"2000","journal-title":"Nutrition"},{"key":"ref_13","first-page":"283","article-title":"The worlds of tea and coffee: Patterns of consumption","volume":"57","author":"Grigg","year":"2002","journal-title":"Geo J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.08.001","article-title":"Caffeinated energy drinks-a growing problem","volume":"99","author":"Reissig","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.295.10.1135","article-title":"Coffee, CYP1A2 genotype, and risk of myocardial infarction","volume":"295","author":"Cornelis","year":"2006","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0278-6915(02)00096-0","article-title":"Effects of caffeine on human behavior","volume":"40","author":"Smith","year":"2002","journal-title":"Food Chem. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1469-8986.1994.tb02345.x","article-title":"Influence of caffeine on selective attention in well-rested and fatigued subjects","volume":"31","author":"Lorist","year":"1994","journal-title":"Psychophysiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00213-006-0341-3","article-title":"Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users","volume":"185","author":"Childs","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-005-0084-6","article-title":"Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation","volume":"182","author":"James","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4610.2006.00376.x","article-title":"Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study","volume":"46","author":"Goldstein","year":"2006","journal-title":"Headache"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1526-4610.2002.02143.x","article-title":"Chronic daily headache: identification of factors associated with induction and transformation","volume":"42","author":"Bigal","year":"2002","journal-title":"Headache"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease","volume":"52","author":"Hernan","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain [\u03b2]-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5694\/j.1326-5377.2001.tb143404.x","article-title":"Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products","volume":"174","author":"Cannon","year":"2001","journal-title":"Med. J. Aust."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0895-4356(99)00044-X","article-title":"Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease","volume":"52","author":"Gorgels","year":"1999","journal-title":"J. Clin. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.CIR.0000046228.97025.3A","article-title":"Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking","volume":"106","author":"Corti","year":"2002","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jama.291.10.1199-b","article-title":"Coffee consumption and insulin sensitivity","volume":"291","author":"Arnlov","year":"2004","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.metabol.2007.07.013","article-title":"Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial","volume":"56","author":"MacKenzie","year":"2007","journal-title":"Metabolism"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2796.2004.01331.x","article-title":"Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women","volume":"255","author":"Agardh","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/dc07-1952","article-title":"Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study","volume":"31","author":"Williams","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.166.11.1190","article-title":"Coffee, cirrhosis, and transaminase enzymes","volume":"166","author":"Klatsky","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/art.22712","article-title":"Coffee consumption and risk of incident gout in men: A prospective study","volume":"56","author":"Choi","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1139\/H08-130","article-title":"Caffeine and sports performance","volume":"33","author":"Burke","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-148-12-200806170-00003","article-title":"The relationship of coffee consumption with mortality","volume":"148","author":"Li","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Boehm, K., Borrelli, F., Ernst, E., Habacher, G., Hung, S.K., Milazzo, S., and Horneber, M. (2009). Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst. Rev., CD005004.","DOI":"10.1002\/14651858.CD005004.pub2"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(01)00653-6","article-title":"Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies","volume":"30","author":"Kanis","year":"2002","journal-title":"Bone"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1001\/jama.298.23.2761","article-title":"Long-term risk of incident vertebral fractures","volume":"298","author":"Cauley","year":"2007","journal-title":"JAMA"},{"key":"ref_39","unstructured":"Ballenger, J.C. (1990). Neurobiology of Panic Disorder, Alan R. Liss Inc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpsyc.1992.01820110031004","article-title":"Anxiogenic effects of caffeine in patients with anxiety disorders","volume":"49","author":"Bruce","year":"1992","journal-title":"Arch Gen. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/00952990600918965","article-title":"Is caffeine addictive?--a review of the literature","volume":"32","author":"Satel","year":"2006","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0149-7634(98)00050-5","article-title":"Are we dependent upon coffee and caffeine? A review on human and animal data","volume":"23","author":"Nehlig","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_43","unstructured":"(2000). Diagnostic and Statistical Manual of Mental Disorders, Text Revision."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-004-2000-x","article-title":"A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features","volume":"176","author":"Juliano","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF01968551","article-title":"Absorption of nicotine through the oral mucosa-measurement of nicotine concentration in the blood after application of nicotine and total particulate matter","volume":"3","author":"Schevelbein","year":"1973","journal-title":"Agents Actions"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jama.280.2.152","article-title":"Nicotine metabolism and intake in black and white smokers","volume":"280","author":"Herrera","year":"1998","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clpt.2004.10.011","article-title":"Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence","volume":"77","author":"Malaiyandi","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajmg.b.30828","article-title":"Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes","volume":"150B","author":"Saccone","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.pa.36.040196.003121","article-title":"Pharmacology of nicotine: addiction and therapeutics","volume":"36","author":"Benowitz","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/clpt.1984.142","article-title":"Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking","volume":"36","author":"Benowitz","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(94)90527-4","article-title":"Mechanism underlying nicotine-induced relaxation in dog saphenous arteries","volume":"263","author":"Okamura","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.mp.4001284","article-title":"Roles of dopamine signaling in nicotine addiction","volume":"8","author":"Dani","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1568007023339102","article-title":"Nicotinic treatment for cognitive dysfunction","volume":"4","author":"Levin","year":"2002","journal-title":"Curr. Drug. Targets CNS Neurol. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1681.1995.tb01986.x","article-title":"Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk","volume":"22","author":"Pickering","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0735-1097(93)90773-T","article-title":"Short and long-term effects of smoking on arterial wall properties in habitual smokers","volume":"22","author":"Kool","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0895-7061(96)00487-6","article-title":"Smoking related to 24-h ambulatory blood pressure and heart rate. A study in 352 normotensive Danish subjects","volume":"10","author":"Mikkelsen","year":"1997","journal-title":"Am J Hypertens."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.CIR.80.5.1309","article-title":"Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers","volume":"80","author":"Benowitz","year":"1989","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1016\/0735-1097(93)90170-6","article-title":"Acute effect of cigarette smoking on the coronary circulation: Constriction of epicardial and resistance vessels","volume":"22","author":"Quillen","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.STR.29.8.1656","article-title":"Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo","volume":"29","author":"Iida","year":"1998","journal-title":"Stroke"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-8703(87)90063-9","article-title":"Fibrinogen, cigarette smoking and the risk of cardiovascular disease from the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(87)92556-6","article-title":"Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease","volume":"2","author":"Meade","year":"1987","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/pmed.1997.0175","article-title":"The role of nicotine in smoking-related cardiovascular disease","volume":"26","author":"Benowitz","year":"1997","journal-title":"Prev. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.STR.30.3.651","article-title":"Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway","volume":"30","author":"Zidovetzki","year":"1999","journal-title":"Stroke"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0735-1097(90)90583-B","article-title":"Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking","volume":"16","author":"Rivers","year":"1990","journal-title":"J. Am.Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/heart.84.3.233","article-title":"Does smoking cessation reduce the risk of restenosis following coronary angioplasty?","volume":"84","author":"Pell","year":"2000","journal-title":"Heart"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.90.1.27","article-title":"Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers","volume":"90","author":"Kiowski","year":"1994","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0002-8703(88)90649-7","article-title":"Lipid effects of smoking","volume":"115","author":"Mjos","year":"1988","journal-title":"Am. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/oxfordjournals.aje.a114702","article-title":"Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: Results from the Lipid Research Clinic Follow-up Study","volume":"126","author":"Criqui","year":"1987","journal-title":"Am. J. Epidemiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.94.5.878","article-title":"Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance","volume":"94","author":"Eliasson","year":"1996","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.109.2.438","article-title":"Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study","volume":"109","author":"Murray","year":"1996","journal-title":"Chest"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199612123352402","article-title":"The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease","volume":"335","author":"Joseph","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0735-1097(01)01124-X","article-title":"Risk of acute first myocardial infarction and use of nicotine patches in a general population","volume":"37","author":"Kimmel","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mrrev.2008.04.002","article-title":"Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: Implications on lung carcinogenesis","volume":"659","author":"Catassi","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1073\/pnas.0509313103","article-title":"Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and surviving","volume":"103","author":"Dasgupta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14622200500494856","article-title":"Clinical significance of tobacco withdrawal","volume":"8","author":"Hughes","year":"2006","journal-title":"Nicotine Tob. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0899-3289(96)90115-7","article-title":"Measuring tobacco withdrawal: a review of self-report questionnaires","volume":"8","author":"Patten","year":"1996","journal-title":"J. Subst. Abuse"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/COPD.S1121","article-title":"The use of bupropion SR in cigarette smoking cessation","volume":"3","author":"Wilkes","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an \u03b14\u03b22 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"ref_82","unstructured":"World Drug Report 2007. Report no. E.07.XI.5. Available online:http:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR-2007.pdf,."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3109\/10826089609063975","article-title":"Epidemiology of coca derivatives use in the Andean region: a tale of five countries","volume":"31","author":"Montoya","year":"1996","journal-title":"Subst. Use Misuse"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00952999509002690","article-title":"Patterns of cocaine use among individuals in substance abuse treatment","volume":"21","author":"Myers","year":"1995","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0740-5472(01)00192-1","article-title":"Cocaine dependence: a disease of the brain's reward centers","volume":"21","author":"Dackis","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/j.1875-9114.1996.tb02974.x","article-title":"The effect of cocaine on Ventricular fibrillation threshold in the normal canine heart","volume":"16","author":"Tisdale","year":"1996","journal-title":"Pharmacotherapy"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjcard.2005.11.046","article-title":"Effect of acute cocaine administration on the QTc interval of habitual users","volume":"97","author":"Magnano","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.1996.03540190052029","article-title":"Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?","volume":"276","author":"Hatsukami","year":"1996","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0735-6757(91)90053-M","article-title":"The contribution of impurities to the acute morbidity of illegal drug use","volume":"9","author":"Shesser","year":"1991","journal-title":"Am. J. Emerg. Med."},{"key":"ref_92","first-page":"37","article-title":"Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis","volume":"29","author":"Ostrea","year":"1999","journal-title":"Curr. Probl. Pediatr."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"(2001). Transfer of drugs and other chemicals into human milk. Pediatrics, 108, 776\u2013789.","DOI":"10.1542\/peds.108.3.776"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.164.5.660","article-title":"Cocaine: patterns of use, route of administration, and severity of dependence","volume":"164","author":"Gossop","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol,controlled substances, and inhalants: Basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"ref_96","unstructured":"(2005). Results from the 2006 National Survey on Drug Use and Health, National Findings; Report no. SMA 07-4293."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00007691-200006000-00006","article-title":"Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: a clarification","volume":"22","author":"Warner","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1360-0443.2002.00158.x","article-title":"Effects of concurrent use of alcohol and cocaine","volume":"97","author":"Pennings","year":"2002","journal-title":"Addiction"},{"key":"ref_99","unstructured":"Engel, J., Oreland, L., and Ingvar, D.H. (1987). Brain Reward Systems and Abuse, Raven Press."},{"key":"ref_100","unstructured":"Higgins, S.T., and Katz, J.L. (1998). Behavior, Pharmacology, and Clinical Applications, Cocaine Abuse Academic Press."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(96)01324-5","article-title":"Adverse effects of stimulant drugs in a community sample of drug users","volume":"44","author":"Williamson","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1176\/ajp.150.1.155","article-title":"Transient compulsive foraging behavior associated with crack cocaine use","volume":"150","author":"Rosse","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000126628","article-title":"Drugs of abuse and sexual functioning","volume":"29","author":"Palha","year":"2008","journal-title":"Adv. Psychosom. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2007.04.049","article-title":"Crack Whips the Heart: A Review of the Cardiovascular Toxicity of Cocaine","volume":"100","author":"Luis","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1468-1331.2000.00045.x","article-title":"Neurological complications of drug abuse: pathophysiological mechanisms","volume":"7","author":"Neiman","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.CIR.103.4.502","article-title":"Cocaine use and the likelihood of nonfatal myocardial infarction and stroke","volume":"103","author":"Qureshi","year":"2001","journal-title":"Circulation"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM200108023450507","article-title":"Cardiovascular complications of cocaine use","volume":"345","author":"Lange","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001648-199811000-00005","article-title":"Stroke and cocaine or amphetamine use","volume":"9","author":"Petitti","year":"1998","journal-title":"Epidemiology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0733-8619(05)70074-8","article-title":"Acute neurologic complications of drug and alcohol abuse","volume":"16","author":"Brust","year":"1998","journal-title":"Neurol. Clin."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-90-3-361","article-title":"Acute toxic and withdrawal reactions associated with drug use and abuse","volume":"90","author":"Khantzian","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0376-8716(99)00126-X","article-title":"Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms","volume":"59","author":"Coffey","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"876","DOI":"10.7326\/0003-4819-111-11-876","article-title":"Myocardial ischemia during cocaine withdrawal","volume":"111","author":"Nademanee","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/clc.4960130505","article-title":"Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population","volume":"13","author":"Bertolet","year":"1990","journal-title":"Clin. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/ajkd.2001.26845","article-title":"Cocaine use, hypertension, and end-stage renal disease","volume":"38","author":"Norris","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0147-9563(97)90040-6","article-title":"Cocaine: Pathophysiology and clinical toxicology","volume":"26","author":"Boghdadi","year":"1997","journal-title":"Heart Lung"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2008.10.034","article-title":"Decreased brain dopamine cell numbers in human cocaine users","volume":"168","author":"Little","year":"2009","journal-title":"Psychiatry Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.rmr.0000192156.46492.24","article-title":"Neuroimaging in drug and substance abuse part I: cocaine, cannabis, and ecstasy","volume":"16","author":"Rojas","year":"2005","journal-title":"Top Magn. Reson. Imaging"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0959-4388(00)00204-X","article-title":"Investigating the neurocognitive deficits associated with chronic drug misuse","volume":"11","author":"Rogers","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-112-12-897","article-title":"Potentiation of cocaine-induced coronary vasoconstriction by \u03b2-adrenergic blockade","volume":"112","author":"Lange","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.annemergmed.2007.04.015","article-title":"\u03b2-blockers are associated with reduced risk of myocardial infarction after cocaine use","volume":"51","author":"Dattilo","year":"2008","journal-title":"Ann. Emerg. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9343(93)90212-8","article-title":"Influence of labetalol on cocaine-induced coronary vasoconstriction in humans","volume":"94","author":"Boehrer","year":"1993","journal-title":"Am. J. Med."},{"key":"ref_122","unstructured":"Schuckit, M.A. (2006). Drug and Alcohol Abuse. A Clinical Guide to Diagnosis and Treatment, Springer. [6th]."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11920-005-0032-5","article-title":"Recent advances in the psychotherapy of addictive disorders","volume":"7","author":"Carroll","year":"2005","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention matter? Treatment duration and improvement in drug use","volume":"98","author":"Zhang","year":"2003","journal-title":"Addiction"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2004.08.012","article-title":"The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients","volume":"77","author":"Weiss","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","article-title":"Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use","volume":"64","author":"Shoptaw","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09595230801927372","article-title":"The principles of agonist pharmacotherapy for psychostimulant dependence","volume":"27","author":"Shearer","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2008.08.009","article-title":"Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy","volume":"99","author":"Rush","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","article-title":"Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse","volume":"9","author":"Weinshenker","year":"2009","journal-title":"Mol. Interv."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/ajem.2000.9282","article-title":"Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED","volume":"18","author":"Blaho","year":"2000","journal-title":"Am. J. Emerg. Med."},{"key":"ref_136","first-page":"1689","article-title":"Substance abuse: the designer drugs","volume":"43","author":"Beebe","year":"1991","journal-title":"Am. Fam. Physician"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJM198712103172419","article-title":"Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, 'ecstasy') on an undergraduate campus","volume":"317","author":"Peroutka","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(96)03410-1","article-title":"Alcohol and drug use in UK university students","volume":"348","author":"Webb","year":"1996","journal-title":"Lancet"},{"key":"ref_139","first-page":"375","article-title":"Long-term effects of \"ecstasy\" use on serotonin transporters of the brain investigated by PET","volume":"44","author":"Buchert","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0278-5846(00)00113-5","article-title":"Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylene-dioxymethamphetamine in the rat","volume":"24","author":"Daws","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_141","first-page":"77","article-title":"Ecstasy: Towards an understanding of the biochemical basis of the actions of MDMA","volume":"26","author":"Rattray","year":"1991","journal-title":"Essays Biochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/j.1326-5377.2001.tb143372.x","article-title":"Poisoning with the recreational drug paramethoxyamphetamine (\u201cdeath\u201d)","volume":"174","author":"Ling","year":"2001","journal-title":"Med. J. Aust."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005053-199206000-00001","article-title":"Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use","volume":"180","author":"Liester","year":"1992","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0924-9338(01)00551-X","article-title":"Subjective effects of MDMA ('Ecstasy') on human sexual function","volume":"16","author":"Zemishlany","year":"2001","journal-title":"Eur. Psychiatry."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jcp.49.2.149","article-title":"Pathology of deaths associated with ecstasy and \u201ceve\u201d misuse","volume":"49","author":"Milroy","year":"1996","journal-title":"J. Clin. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2044.1993.tb07102.x","article-title":"Ecstasy intoxication: appreciation of complications and the role of dantrolene","volume":"48","author":"Webb","year":"1993","journal-title":"Anaesthesia"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","article-title":"Toxicity and deaths from 3,4-metylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"340","author":"Henry","year":"1992","journal-title":"Lancet"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09595230220119363","article-title":"The health effects of ecstasy : a litterature review","volume":"21","author":"Gowing","year":"2002","journal-title":"Drug Alcohol Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/clpt.2009.62","article-title":"Cannabis coadministration potentiates the effects of \"ecstasy\" on heart rate and temperature in humans","volume":"86","author":"Dumont","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-133-12-200012190-00012","article-title":"Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial","volume":"133","author":"Lester","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0149-7634(98)00046-3","article-title":"3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans","volume":"23","author":"Hegadoren","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_152","first-page":"821","article-title":"Mood and cognitive effects of +\/- 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d): week-end high followed by mid-week low","volume":"92","author":"Curran","year":"1997","journal-title":"Addiction"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0278-5846(97)00045-6","article-title":"Neuropsychiatric manifestation following the use of 3,4-methylenedioxymethamphetamine (MDMA: ecstasy)","volume":"21","author":"Cohen","year":"1997","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/0140-6736(91)92332-V","article-title":"Psychiatric illness associated with ecstasy","volume":"338","author":"Benazzi","year":"1991","journal-title":"Lancet"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-3223(92)90145-P","article-title":"MDMA (ecstasy) precipitation of panic disorder","volume":"32","author":"Pallanti","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1192\/bjp.175.2.186","article-title":"Ecstasy \u2013 long term effects on the human central nervous system revealed by positron emission tomography","volume":"175","author":"Obrocki","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.55.2.294","article-title":"Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user","volume":"55","author":"Kish","year":"2000","journal-title":"Neurology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.51.6.1532","article-title":"Memory impairment in abstinent MDMA (ecstasy) users","volume":"51","author":"Bolla","year":"1998","journal-title":"Neurology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1348\/000712600161772","article-title":"Working memory deficits in current and previous users of MDMA (\u201cecstasy\u201d)","volume":"91","author":"Wareing","year":"2000","journal-title":"Br. J. Psychol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/bja\/79.6.697","article-title":"Ecstasy and the anaesthetist","volume":"79","author":"Hall","year":"1997","journal-title":"Br. J. Anaest."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.09.009","article-title":"Is ecstasy a drug of dependence?","volume":"107","author":"Degenhardt","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0376-8716(99)00002-2","article-title":"Ecstasy use in Australia: pattern of use and assiociated harms","volume":"55","author":"Topp","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4088\/JCP.v60n0711a","article-title":"Effects of ecstasy blocked by serotonin reuptake inhibitors","volume":"60","author":"Stein","year":"1999","journal-title":"J. Clin..Psychiatry"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta13060","article-title":"The harmful health effects of recreational ecstasy: a systematic review of observational evidence","volume":"13","author":"Rogers","year":"2009","journal-title":"Health Technol. Assess"},{"key":"ref_165","unstructured":"Methamphetamine use: 2002, 2003, 2004 and 2005, NSDUH Report. Available online:http:\/\/www.drugabusestatistics.samhsa.gov\/2k7\/meth\/meth.pdf\/."},{"key":"ref_166","unstructured":"Methamphetamine Use, Abuse, and Dependence: 2002, 2003, and 2004, NSDUH Report. Available online:http:\/\/www.drugabusestatistics.samhsa.gov\/2k5\/meth\/meth.htm\/."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/aje\/kwh135","article-title":"Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men","volume":"59","author":"Colfax","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_168","first-page":"228","article-title":"Methamphetamine laboratory explosions: a new and emerging burn injury","volume":"26","author":"Santos","year":"2005","journal-title":"J. Burn Care Rehabil."},{"key":"ref_169","unstructured":"Smoked Methamphetamine\/amphetamine: 1992-2002; DASIS Report. Available online:http:\/\/www.oas.samhsa.gov\/2k4\/methSmoked\/methSmoked.pdf\/."},{"key":"ref_170","unstructured":"(2004). Methamphetamine abuse. Med. Lett. Drugs Ther., 46, 62\u201363."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","article-title":"Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors","volume":"291","author":"Volkow","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_172","first-page":"84","article-title":"Methamphetamine use in urban gay and bisexual populations","volume":"14","author":"Shoptaw","year":"2006","journal-title":"Top HIV Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2006.04.007","article-title":"The relationship between crystalline methamphetamine use and dependence","volume":"58","author":"McKetin","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03259928","article-title":"\"Designer drugs\u201d. A problem in clinical toxicology","volume":"3","author":"Buchanan","year":"1988","journal-title":"Med Toxicol AdverseDrug Exp."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0736-4679(03)00031-3","article-title":"Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use","volume":"24","author":"Turnipseed","year":"2003","journal-title":"J. Emerg. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0736-4679(89)90263-1","article-title":"Amphetamine toxicity: experience with 127 cases","volume":"7","author":"Derlet","year":"1989","journal-title":"J. Emerg. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.2008.02231.x","article-title":"Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology","volume":"103","author":"Kaye","year":"2008","journal-title":"Addiction"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1176\/appi.ajp.160.9.1699","article-title":"Association of dopamine transporter loss in the orbitofrontal and dorsolateralprefrontal cortices with methamphetamine-related psychiatric symptoms","volume":"160","author":"Sekine","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Srisurapanont, M., Jarusuraisin, N., and Kittirattanapaiboon, P. (2001). Treatment for amphetamine dependence and abuse. Cochrane Database Syst. Rev., CD003022.","DOI":"10.1002\/14651858.CD003022"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2009.10400669","article-title":"Khat use: lifestyle or addiction?","volume":"41","author":"Manghi","year":"2009","journal-title":"J. Psychoactive Drugs"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ptr.1106","article-title":"Khat: pharmacological and medical aspects and its social use in Yemen","volume":"16","author":"Baker","year":"2002","journal-title":"Phytother. Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0378-8741(95)90038-1","article-title":"Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.)","volume":"49","author":"Halket","year":"1995","journal-title":"J. Ethnopharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/clpt.1994.69","article-title":"Pharmacodynamics and pharmacokinetics of khat: a controlled study","volume":"55","author":"Widler","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1080\/j.1440-1614.2005.01688_4.x","article-title":"Khat chewing: an emerging drug concern in Australia?","volume":"39","author":"Stefan","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00127-003-0596-5","article-title":"Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees-preliminary communication","volume":"38","author":"Bhui","year":"2003","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2125.1990.tb05447.x","article-title":"Amphetamine-like effects in humans of the khat alkaloid cathinone","volume":"30","author":"Brenneisen","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0740-5472(88)90005-0","article-title":"Khat: A Plant with Amphetamine Effects","volume":"5","author":"Kalix","year":"1988","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0714.2004.00145.x","article-title":"A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni","volume":"33","author":"Ali","year":"2004","journal-title":"J. Oral Pathol. Med."},{"key":"ref_190","first-page":"106","article-title":"Khat-chewing during pregnancy-effect upon the off-spring and some characteristics of the chewers","volume":"68","author":"Eriksson","year":"1991","journal-title":"East. Afr. Med. J."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0740-5472(92)90034-L","article-title":"Treatment of Khat addiction","volume":"9","author":"Giannini","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00045391-199506000-00008","article-title":"Treatment of Khat Addiction with Bromocriptine Mesylate: A Case Report and Review of Cocaine- and Amphetamine-Like Effects","volume":"2","author":"Giannini","year":"1995","journal-title":"Am. J. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMp068010","article-title":"The changing face of teenage drug abuse - The trend toward prescription drugs","volume":"354","author":"Friedman","year":"2006","journal-title":"N.Engl. J. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jama.297.12.1306","article-title":"Prescription drug abuse rises globally","volume":"297","author":"Kuehn","year":"2007","journal-title":"JAMA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(07)60690-4","article-title":"Prescription drug abuse up sharply in the USA","volume":"369","author":"McCarthy","year":"2007","journal-title":"Lancet"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0885-3924(95)00187-5","article-title":"Opioid therapy for chronic non-malignant pain: a review of critical issues","volume":"11","author":"Portenoy","year":"1996","journal-title":"J. PainSymptom. Manage."},{"key":"ref_197","unstructured":"Wilford, B.B. (1990). Balancing the Response to Prescription Drug Abuse: Report of a National Symposium on Medicine and Public Policy, American Medical Association."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0025-7125(05)70558-7","article-title":"Prescription drug abuse. A question of balance","volume":"81","author":"Parran","year":"1997","journal-title":"Med. Clin. North Am."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","article-title":"Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"69","author":"Adler","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/sleep\/14.3.218","article-title":"Relative efficacy of drugs for the treatment of sleepiness in narcolepsy","volume":"14","author":"Mitler","year":"1991","journal-title":"Sleep"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00228-005-0921-x","article-title":"Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation","volume":"61","author":"Hugtenburg","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2005.10.020","article-title":"Abuse of prescription drugs and the risk of addiction","volume":"83","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/7\/2333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:02:59Z","timestamp":1760220179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/7\/2333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":202,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7]]}},"alternative-id":["ph3072333"],"URL":"https:\/\/doi.org\/10.3390\/ph3072333","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}